GeoVax at World Vaccine Congress Europe 2026

Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website

GeoVax takes part in 1 session at World Vaccine Congress Europe 2026 in Amsterdam, and exhibits. Its program centres on MVA (modified vaccinia Ankara), the viral platform behind its vaccines. It covers single-dose MVA vaccines and a continuous manufacturing process that grows them in a cell line.

OrganizationWorld Vaccine Congress Europe 2026 Attendance
GeoVax
Smyrna, GA
geovax.com
BiotechShowcase sponsor
Biotech developing MVA-based vaccines and immunotherapies for infectious diseases and cancer.
Booth
Exhibiting (no floor booth listed)
Talk
Mon Oct 19
11:00
Revolutionizing MVA – single dose and continuous cell-line manufacturing
Workshop: Platform Technologies

Explore the full World Vaccine Congress Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full World Vaccine Congress Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from GeoVax

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Terrapinn or the World Vaccine Congress. Submit a correction